Amalgamated Bank Oric Pharmaceuticals, Inc. Transaction History
Amalgamated Bank
- $11.7 Billion
- Q1 2025
A detailed history of Amalgamated Bank transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,130 shares of ORIC stock, worth $20,874. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,130
Previous 2,130
-0.0%
Holding current value
$20,874
Previous $17,000
29.41%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$64.4 Million0.12% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$51.8 Million6.85% of portfolio
-
Nextech Invest Ag5.29MShares$51.8 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$47.3 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$39.2 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $388M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...